Results for: dan horner

UK Resuscitationist #FOAMed #stemlynsLIVE

The UK Resuscitationist from #stemlynsLIVE with Dan Horner. St Emlyn’s

So Dan – we want you to give this talk – about a job. A job that doesn’t exist. Or maybe it’s a thing – but we’re not sure what that is. Or maybe it’s

VTE masterclass with Dan Horner at #RCEM15

You don’t need me to tell you that VTE is a huge problem. 10 million cases worldwide, a cost to the NHS of £466,000,000 and half a million European deaths every year spell it out.

D

Dr Daniel Horner

Dr Daniel Horner BA MBBS MD PgCert MRCP (UK) FRCEM FFICM Editorial Board Member St Emlyn’s blog and podcast Professor of the Royal College of Emergency Medicine Consultant in Emergency Medicine and Intensive Care,  Salford

N

New NICE guidance on Investigation of DVT in the ED

Is Venous Thrombo Embolism the most controversial area of EM practice at the moment? I think it might be as there is rarely a meeting or conference where the subject is not discussed and debated.

Cauda Equina

JC: Re-evaluating risk factors for Cauda Equina. St Emlyn’s

The diagnosis of cauda equina in the emergency department is complex and has the potential for significant patient harm if we get it wrong. Linda Dykes put together an excellent infographic on this back in

JC: Thromboprophylaxis for the non ICU hospitalised COVID-19 patient. St Emlyn’s

Back in March we reported on a pre-print trial of thromboprophylaxis of ICU patients. The results suggested that there was no benefit for therapeutic dose anticoagulation in COVID19 as a prophylactic strategy for critically ill patients with COVID19. This

thromboprophylaxis

JC: Thromboprophylaxis on the ICU for COVID-19 patients. St Emlyn’s

The prevention of venous thromboembolism (VTE) has been a real concern in the management of hospitalised patients with COVID-19. We have previously discussed the role of prophylactic anticoagulation (thromboprophylaxis) for these patients as it was

convalescent plasma

JC: Convalescent plasma (still) does not work in COVID-19. St Emlyn’s

The latest results on the use of convalescent plasma in Covid-19 are now out from the RECOVERY trial as a pre-print. As you know we have already covered the trial quite extensively and thus far

tocilizumab

JC: RECOVERY trial shows Tocilizumab effective for COVID19. St Emlyn’s

In arguably the most important therapeutic news of the pandemic since Dexamethasone, the RECOVERY trial investigators have revealed the initial results on the Tocilizumab arm of the trial showing a significant benefit. This short blog

Oxygen targets in critical care: The HOT-ICU trial. St Emlyn’s

Oxygen targets in critically ill/injured patients has been something we’ve talked about on the blog before. In general the evidence to date has suggested that the routine prescription of oxygen to patients is unhelpful and